Taysha Gene Therapies reported cash from operations of -$40.42M and free cash flow of -$40.78M for the quarter ended Jun 2026, down 100.3% year over year. This cash flow statement covers 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||
| Net Income | -51.19M | -50.39M | -50.31M | -34.09M | -26.53M | -55.07M | -17.61M | -24.60M | -16.61M | -15.04M | -22.67M | -19.89M | -23.82M | -18.25M | -20.11M | -24.91M | -30.87M | -25.44M | -40.91M | -45.03M | |||||||
| Share-based Compensation | 5.09M | 4.96M | 5.44M | 5.15M | 4.55M | 4.10M | 5.23M | 2.41M | 2.57M | 1.97M | 4.53M | 3.40M | 3.36M | 3.22M | 4.71M | 3.46M | 23.59M | 3.53M | 5.55M | 5.81M | |||||||
| Gains from Investment Securities | -65.74M | 0.34M | -0.20M | -0.07M | -0.08M | -0.10M | 0.27M | 0.29M | 0.74M | ||||||||||||||||||
| Asset Writedowns and Impairment | 0.62M | 0.45M | 4.84M | ||||||||||||||||||||||||
| Cash from Operations | -31.93M | -40.26M | -40.94M | -33.35M | -28.81M | 14.71M | -20.18M | -18.77M | -17.95M | -16.12M | -19.80M | -21.50M | -21.61M | -18.31M | -22.02M | -20.18M | -24.17M | -26.72M | -40.88M | -40.42M | |||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.31M | 0.34M | 0.39M | 0.28M | 0.30M | 0.30M | 0.30M | 0.27M | 0.33M | 0.29M | 0.30M | 0.30M | 0.34M | 0.31M | 0.31M | 0.40M | 0.28M | 0.27M | |||||||||
| Change in Working Capital | |||||||||||||||||||||||||||
| Change in Account Payables | 13.62M | -1.51M | 2.54M | 3.67M | -9.43M | -4.59M | 0.36M | 1.76M | -3.19M | -1.23M | 3.98M | -1.61M | -3.78M | -1.50M | 0.92M | 3.00M | -1.95M | -2.13M | 1.29M | 4.56M | |||||||
| Change in Accured Expenses | -2.87M | 5.36M | -0.78M | -7.68M | -0.12M | -0.75M | -0.25M | -1.07M | -2.94M | -2.02M | 0.42M | -2.38M | 0.43M | 0.11M | -2.12M | 0.73M | 5.01M | 2.67M | -5.15M | 0.86M | |||||||
| Other Working Capital Changes | -1.75M | 1.83M | -0.27M | 0.19M | -1.90M | -0.11M | 0.40M | -0.91M | -3.50M | -2.00M | 0.69M | -0.82M | 0.74M | -0.82M | 1.05M | -0.48M | -0.97M | 2.13M | 0.79M | 0.65M | |||||||
| Investing Activities | |||||||||||||||||||||||||||
| Capital Expenditures | 3.50M | 8.27M | 8.43M | 7.86M | 2.02M | 2.31M | 3.90M | -0.05M | 0.02M | 0.14M | 0.30M | -0.07M | -0.00M | 0.38M | 0.03M | 0.08M | 0.25M | 0.02M | 0.35M | ||||||||
| Cash from Investing Activities | -4.00M | -8.52M | -11.43M | -8.11M | -3.02M | -2.37M | -3.90M | 0.05M | -3.49M | -0.01M | -0.14M | -0.20M | -0.04M | 0.01M | -0.37M | 0.06M | -0.05M | -0.25M | -3.02M | 0.00M | |||||||
| Financing Activities | |||||||||||||||||||||||||||
| Other financing activities | 0.28M | -1.04M | 0.06M | -0.33M | 0.05M | -0.21M | -0.10M | 74.59M | -0.03M | -0.01M | -0.17M | 0.04M | -0.08M | 0.15M | -0.32M | 1.88M | 0.52M | 0.44M | |||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||||
| Long-Term Debt Issuances | 10.00M | ||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.42M | 3.19M | 1.90M | 0.78M | 4.78M | 1.77M | 1.43M | 0.05M | 1.52M | 7.80M | 1.42M | 1.38M | 11.72M | 7.44M | 1.72M | 0.34M | 11.01M | 2.67M | 0.73M | ||||||||
| Net Equity Issued and Repurchased | 0.04M | 16.08M | |||||||||||||||||||||||||
| Misc. | |||||||||||||||||||||||||||
| Cash from Financing Activities | 9.11M | -0.11M | 11.07M | -0.10M | 41.23M | -0.37M | 0.38M | 140.63M | -4.25M | -0.02M | 70.47M | 6.59M | -0.36M | -0.05M | 216.29M | 8.80M | 49.56M | 0.71M | 216.66M | ||||||||
| Change in Cash | -5.96M | -39.67M | -52.47M | -30.39M | -31.93M | 53.57M | -24.45M | -18.34M | 119.19M | -20.38M | -19.96M | 48.76M | -15.05M | -18.65M | -22.44M | 196.17M | -15.42M | 22.59M | -43.19M | 176.23M | |||||||
| Free Cash Flow | -35.44M | -48.53M | -49.37M | -41.22M | -30.83M | 12.40M | -24.09M | -18.72M | -17.95M | -16.13M | -19.94M | -21.81M | -21.55M | -18.31M | -22.40M | -20.21M | -24.24M | -26.97M | -40.90M | -40.78M | |||||||
| Net Cash Flow | -35.94M | -39.67M | -52.47M | -30.39M | -31.93M | 53.57M | -24.45M | -18.34M | 119.19M | -20.38M | -19.96M | 48.76M | -15.05M | -18.65M | -22.44M | 196.17M | -15.42M | 22.59M | -43.19M | 176.23M |